supplier
Orifarm UK
as a supplier
7 recorded awards from 2 buyers , between 23 Apr 2023 and 30 Jun 2025.
awards won
7
exclusive
0%
0 sole-winner awards
median award
£624.1m
largest
£986.3m
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
sells to
| buyer | awards |
|---|---|
| NHS England | 6 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 1 |
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared | NHS England | £986,282,758 | 30 Jun 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared | NHS England | £261,895,933 | 24 Jun 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared | NHS England | £1,241,520,444 | 24 Mar 2025 |
| NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | £304,504,000 | 23 Apr 2023 |
| NP47825 Multiple Sclerosis Medicines shared | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | · | 2 May 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 shared | NHS England | · | 22 Apr 2025 |
| NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | · | 6 Apr 2023 |